New allegations against Armstrong

Barely three weeks after the Vrijman report dismissed L'Equipe's allegations that Lance Armstrong used EPO in 1999, the now retired seven-time Tour champion has come under fire from another angle. French newspaper Le Monde is reporting in its Friday edition that Armstrong admitted to using performance enhancing drugs prior to contracting testicular cancer in 1996.

The allegations were made during the SCA Promotions vs. Armstrong trial that concluded in February. SCA Promotions is an insurance company that paid Armstrong millions of dollars for his Tour wins after the team took out a $420,000 insurance policy in 2001. But following the publication of David Walsh and Pierre Ballester's book, LA Confidentiel, les secrets de Lance Armstrong, which alleged that Armstrong had used illegal drugs, SCA disputed the $5 million payment for the 2004 Tour, saying that it wanted evidence (Armstrong's medical records, for example) that the allegations were untrue.